.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Accenture
Baxter
Chubb
Moodys
AstraZeneca
McKesson
Boehringer Ingelheim
Queensland Health
Express Scripts

Generated: February 18, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Denmark Patent: 1044/93

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Novo Nordisk IncLEVEMIRinsulin detemir recombinantINJECTABLE;SUBCUTANEOUS021536-001Jun 16, 2005RXYesYes➤ Try a Free Trial➤ Try a Free TrialYYLEVEMIR IS A LONG-ACTING BASAL INSULIN ANALOG THAT IS INDICATED IN THE TREATMENT OF PATIENTS WITH DIABETES MELLITUS
Novo Nordisk IncLEVEMIR FLEXPENinsulin detemir recombinantINJECTABLE;SUBCUTANEOUS021536-002Jun 16, 2005DISCNNoNo➤ Try a Free Trial➤ Try a Free TrialYYLEVEMIR IS A LONG-ACTING BASAL INSULIN ANALOG THAT IS INDICATED IN THE TREATMENT OF PATIENTS WITH DIABETES MELLITUS
Novo Nordisk IncLEVEMIR FLEXTOUCHinsulin detemir recombinantINJECTABLE;SUBCUTANEOUS021536-005Oct 31, 2013RXYesYes➤ Try a Free Trial➤ Try a Free TrialYYLEVEMIR IS A LONG-ACTING BASAL INSULIN ANALOG THAT IS INDICATED IN THE TREATMENT OF PATIENTS WITH DIABETES MELLITUS
Novo Nordisk IncLEVEMIR INNOLETinsulin detemir recombinantINJECTABLE;SUBCUTANEOUS021536-003Jun 16, 2005DISCNNoNo➤ Try a Free Trial➤ Try a Free TrialYYLEVEMIR IS A LONG-ACTING BASAL INSULIN ANALOG THAT IS INDICATED IN THE TREATMENT OF PATIENTS WITH DIABETES MELLITUS
Novo Nordisk IncLEVEMIR PENFILLinsulin detemir recombinantINJECTABLE;SUBCUTANEOUS021536-004Jun 16, 2005DISCNNoNo➤ Try a Free Trial➤ Try a Free TrialYYLEVEMIR IS A LONG-ACTING BASAL INSULIN ANALOG THAT IS INDICATED IN THE TREATMENT OF PATIENTS WITH DIABETES MELLITUS
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist